NervGen Pharma Corp. Common stock
NervGen Pharma Corp. Common stock (NGEN) Stock Overview
Explore NervGen Pharma Corp. Common stock’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
285.2M
P/E Ratio
-14.71
EPS (TTM)
$-0.27
ROE
2391.19%
NGEN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of NervGen Pharma Corp. Common stock (NGEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 39.57, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -14.71 and a market capitalization of 285.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.